amarex relationship was rocky for years...would love to be
amarex relationship was rocky for years...would love to be a fly on the wall in the arbitration, this story is very complicated. so many questions, correct me if im wrong...
cytodyn had balked on payments for invoices dating back years, isnt the total owed at this point in the $80 million range? why were the initial unpaid invoices tolerated, and why did amarex continue to perform work on new invoices? if the work was unsatisfactory and not worthy of payment, why continue to work with amarex going forward, for years? wouldnt any violations nullify the contract between them? if the contract gets nullified, do trials have to be redone or can the data be used by the next CRO?
its seems obvious that amarex's position on the incomplete BLA submission is rooted in the amount owed for past invoices, and they will claim nader "rushed" them and demanded the submission "as is" immediately.
what is also obvious is amarex should have had plenty of time and data to prepare a completed document, there really is no excuse not to at all. if there were problems along the way, wouldnt cytodyn be aware of them and try correct any issues? did cytodyn get to review the BLA before submission and potentially abort because it was a joke?
it is painfully obvious that they intentionally sabotaged the BLA, bought a lot of time for whoever is really responsible, delaying leronlimab from market for years. well done. i am not alone in being far more concerned about the people that were denied treatment ( people i KNEW) than worrying about some money i am currently missing. far more concerned about the people i KNOW that could possibly be helped / cured while waiting for this nonsense to conclude.
the shorts, the feuersteins, the andrew lefts, the kazempours etc etc etc all have that tonya harding quality about them...whack nancy kerrigan in the kneecaps so there is no way she can compete...in other words...cheat.
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...
Continue Reading
New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...
Continue Reading
Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...
Continue Reading
Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...
Continue Reading
Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...
Continue Reading
Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...
Continue Reading
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Top 5 Most Recently Viewed Articles
Remarkable Surge of Australian Oilseeds Holdings Shares of Australian Oilseeds Holdings Ltd. (NASDAQ: COOT) experienced an astonishing increase, rising 248.19% in after-hours trading. Following this surge, the stock closed at an impressive $3.36, marking a significant shift in investor interest. Political Factors Influencing Market Movements Recently, political activities...
Continue Reading
EIB Submits SEC Form 18-K/A Amendment No. 4 On a recent date, the European Investment Bank (EIB) took a significant step by submitting SEC Form 18-K/A Amendment No. 4. This submission provides important updates regarding the bank's financial status and operations for the first half of the year. Understanding the Importance of This Submission This amendment is particularly...
Continue Reading
Understanding the Impact of Unmanaged Contracts on Business Workday's recent research sheds light on a pressing issue affecting businesses today: unmanaged contracts. The study highlights that a staggering 76% of employees are unclear about who is responsible for contract ownership, leading to lost revenue and overlooked opportunities. Contracts serve a crucial role in...
Continue Reading
Understanding the Legal Landscape for PubMatic, Inc. Recently, there has been considerable attention on PubMatic, Inc. This attention arises from a legal investigation by prominent law firm Pomerantz LLP aimed at examining claims on behalf of investors of the company. The Investigation Details Pomerantz LLP has taken a proactive stance in uncovering whether PubMatic and...
Continue Reading
DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...
Continue Reading